For AD therapy, we established F3.ChAT cells over-expressing the human ChAT gene by transfecting the ChAT gene into the HB1.F3 cell line—the F3.ChAT cells recovered brain ACh level and memory function in aged mice and transgenic and neurotoxin-induced AD model animals [4,14,15,16]. This evidence concerns the gene CHAT and Alzheimer disease.